[1]
|
Hassoun, P.M. (2021) Pulmonary Arterial Hypertension. The New England Journal of Medicine, 385, 2361-2376.
https://doi.org/10.1056/NEJMra2000348
|
[2]
|
Ruopp, N.F. and Cockrill, B.A. (2022) Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review. JAMA, 327, 1379-1391. https://doi.org/10.1001/jama.2022.4402
|
[3]
|
Han, B., Bu, P., Meng, X., et al. (2017) Microarray Profiling of Long Non-Coding RNAs Associated with Idiopathic Pulmonary Arterial Hypertension. Experimental and Therapeutic Medicine, 13, 2657-2666.
https://doi.org/10.3892/etm.2017.4355
|
[4]
|
Okazaki, Y., Furuno, M., Kasukawa, T., et al. (2002) Analysis of the Mouse Transcriptome Based on Functional Annotation of 60,770 Full-Length cDNAs. Nature, 420, 563-73. https://doi.org/10.1038/nature01266
|
[5]
|
Mattick, J.S. and Makunin, I.V. (2006) Non-Coding RNA. Human Molecular Genetics, 15, R17-R29.
https://doi.org/10.1093/hmg/ddl046
|
[6]
|
Han, Y., Ali, M.K., Dua, K., et al. (2021) Role of Long Non-Coding RNAs in Pulmonary Arterial Hypertension. Cell, 10, Article No. 1892. https://doi.org/10.3390/cells10081892
|
[7]
|
Mercer, T.R., Dinger, M.E. and Mattick, J.S. (2009) Long Non-Coding RNAs: Insights into Functions. Human Molecular Genetics, 10, 155-159. https://doi.org/10.1038/nrg2521
|
[8]
|
Beermann, J., Piccoli, M.T., Viereck, J., et al. (2016) Non-Coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches. Physiological Reviews, 96, 1297-1325.
https://doi.org/10.1152/physrev.00041.2015
|
[9]
|
Sun, M., Nie, F., Wang, Y., et al. (2016) LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT. Cancer Research, 76, 6299-6310.
https://doi.org/10.1158/0008-5472.CAN-16-0356
|
[10]
|
Gasri-Plotnitsky, L., Ovadia, A., Shamalov, K., et al. (2017) A Novel lncRNA, GASL1, Inhibits Cell Proliferation and Restricts E2F1 Activity. Oncotarget, 8, 23775-23786. https://doi.org/10.18632/oncotarget.15864
|
[11]
|
Peng, W.X., Koirala, P. and Mo, Y.Y. (2017) LncRNA-Mediated Regulation of Cell Signaling in Cancer. Oncogene, 36, 5661-5667. https://doi.org/10.1038/onc.2017.184
|
[12]
|
Leeper, N.J. and Maegdefessel, L. (2018) Non-Coding RNAs: Key Regulators of Smooth Muscle Cell Fate in Vascular Disease. Cardiovascular Research, 114, 611-621. https://doi.org/10.1093/cvr/cvx249
|
[13]
|
Haemmig, S., Simion, V. and Feinberg, M.W. (2018) Long Non-Coding RNAs in Vascular Inflammation. Frontiers in Cardiovascular Medicine, 5, Article No. 22. https://doi.org/10.3389/fcvm.2018.00022
|
[14]
|
Leimena, C. and Qiu, H. (2018) Non-Coding RNA in the Pathogenesis, Progression and Treatment of Hypertension. International Journal of Molecular Sciences, 19, Article No. 927. https://doi.org/10.3390/ijms19040927
|
[15]
|
Chi, Y., Wang, D., Wang, J., et al. (2019) Long Non-Coding RNA in the Pathogenesis of Cancers. Cells, 8, Article No. 1015. https://doi.org/10.3390/cells8091015
|
[16]
|
Simion, V., Haemmig, S. and Feinberg, M.W. (2019) LncRNAs in Vascular Biology and Disease. Vascular Pharmacology, 114, 145-156. https://doi.org/10.1016/j.vph.2018.01.003
|
[17]
|
Wolowiec, L., Medlewska, M., Osiak, J., et al. (2023) MicroRNA and lncRNA as the Future of Pulmonary Arterial Hypertension Treatment. International Journal of Molecular Sciences, 24, Article No. 9735.
https://doi.org/10.3390/ijms24119735
|
[18]
|
WKovacs, G., Dumitrescu, D., Barner, A., et al. (2018) Definition, Clinical Classification and Initial Diagnosis of Pulmonary Hypertension: Updated Recommendations from the Cologne Consensus Conference 2018. International Journal of Cardiology, 272S, 11-19. https://doi.org/10.1016/j.ijcard.2018.08.083
|
[19]
|
Vaillancourt, M., Ruffenach, G., Meloche, J., et al. (2015) Adaptation and Remodelling of the Pulmonary Circulation in Pulmonary Hypertension. Canadian Journal of Cardiology, 31, 407-415. https://doi.org/10.1016/j.cjca.2014.10.023
|
[20]
|
Sommer, N., Ghofrani, H.A., Pak, O., et al. (2021) Current and Future Treatments of Pulmonary Arterial Hypertension. British Journal of Pharmacology, 178, 6-30. https://doi.org/10.1111/bph.15016
|
[21]
|
Leopold, J.A. and Maron, B.A. (2016) Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension. International Journal of Molecular Sciences, 17, Article No. 761.
https://doi.org/10.3390/ijms17050761
|
[22]
|
Price, L.C., Wort, S.J., Perros, F., et al. (2012) Inflammation in Pulmonary Arterial Hypertension. Chest, 141, 210-221.
https://doi.org/10.1378/chest.11-0793
|
[23]
|
Nogueira-Ferreira, R., Vitorino, R., Ferreira, R., et al. (2015) Exploring the Monocrotaline Animal Model for the Study of Pulmonary Arterial Hypertension: A Network Approach. Pulmonary Pharmacology & Therapeutics, 35, 8-16.
https://doi.org/10.1016/j.pupt.2015.09.007
|
[24]
|
Rieg, A.D., Suleiman, S., Anker, C., et al. (2018) PDGF-BB Regulates the Pulmonary Vascular Tone: Impact of Prostaglandins, Calcium, MAPK- and PI3K/AKT/mTOR Signalling and Actin Polymerisation in Pulmonary Veins of Guinea Pigs. Respiratory Research, 19, Article No. 120. https://doi.org/10.1186/s12931-018-0829-5
|
[25]
|
Qian, Z., Li, Y., Chen, J., et al. (2017) miR-4632 Mediates PDGF-BB-Induced Proliferation and Antiapoptosis of Human Pulmonary Artery Smooth Muscle Cells via Targeting cJUN. American Journal of Physiology-Cell Physiology, 313, C380-C391. https://doi.org/10.1152/ajpcell.00061.2017
|
[26]
|
Tan, W.S.D., Liao, W., Zhou, S., et al. (2018) Targeting the Renin-Angiotensin System as Novel Therapeutic Strategy for Pulmonary Diseases. Current Opinion in Pharmacology, 40, 9-17. https://doi.org/10.1016/j.coph.2017.12.002
|
[27]
|
Viswanathan, G., Mamazhakypov, A., Schermuly, R.T., et al. (2018) The Role of G Protein-Coupled Receptors in the Right Ventricle in Pulmonary Hypertension. Frontiers in Cardiovascular Medicine, 5, Article No. 179.
https://doi.org/10.3389/fcvm.2018.00179
|
[28]
|
De Man, F.S., Tu, L., Handoko, M.L., et al. (2012) Dysregulated Renin-Angiotensin-Aldosterone System Contributes to Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine, 186, 780-790.
https://doi.org/10.1164/rccm.201203-0411OC
|
[29]
|
Gupta, V.S. and Harting, M.T. (2020) Congenital Diaphragmatic Hernia-Associated Pulmonary Hypertension. Seminars in Perinatology, 44, Article ID: 151167. https://doi.org/10.1053/j.semperi.2019.07.006
|
[30]
|
Longoni, M., Russell, M.K., High, F.A., et al. (2015) Prevalence and Penetrance of ZFPM2 Mutations and Deletions Causing Congenital Diaphragmatic Hernia. Clinical Genetics, 87, 362-367. https://doi.org/10.1111/cge.12395
|
[31]
|
McCulley, D.J., Wienhold, M.D., Hines, E.A., et al. (2018) PBX Transcription Factors Drive Pulmonary Vascular Adaptation to Birth. Journal of Clinical Investigation, 128, 655-667. https://doi.org/10.1172/JCI93395
|
[32]
|
Cao, Y., Yang, Y., Wang, L., et al. (2018) Analyses of Long Non-Coding RNA and mRNA Profiles in Right Ventricle Myocardium of Acute Right Heart Failure in Pulmonary Arterial Hypertension Rats. Biomedicine & Pharmacotherapy, 106, 1108-1115. https://doi.org/10.1016/j.biopha.2018.07.057
|
[33]
|
Zahid, K.R., Raza, U., Chen, J., et al. (2020) Pathobiology of Pulmonary Artery Hypertension: Role of Long Non-Coding RNAs. Cardiovascular Research, 116, 1937-1947. https://doi.org/10.1093/cvr/cvaa050
|
[34]
|
Awad, K.S., West, J.D., de Jesus Perez, V., et al. (2016) Novel Signaling Pathways in Pulmonary Arterial Hypertension (2015 Grover Conference Series). Pulmonary Circulation, 6, 285-294. https://doi.org/10.1086/688034
|
[35]
|
Wilson, J.L., Yu, J., Taylor, L., et al. (2015) Hyperplastic Growth of Pulmonary Artery Smooth Muscle Cells from Subjects with Pulmonary Arterial Hypertension Is Activated through JNK and p38 MAPK. PLOS ONE, 14, e0123662.
https://doi.org/10.1371/journal.pone.0123662
|
[36]
|
Wang, J., Feng, W., Li, F., et al. (2019) SphK1/S1P Mediates TGF-β1-Induced Proliferation of Pulmonary Artery Smooth Muscle Cells and Its Potential Mechanisms. Pulmonary Circulation, 9, 1-8.
https://doi.org/10.1177/2045894018816977
|
[37]
|
Wang, D., Xu, H., Wu, B., et al. (2019) Long Non‑Coding RNA MALAT1 Sponges miR‑124‑3p.1/KLF5 to Promote Pulmonary Vascular Remodeling and Cell Cycle Progression of Pulmonary Artery Hypertension. International Journal of Molecular Medicine, 44, 871-884. https://doi.org/10.3892/ijmm.2019.4256
|
[38]
|
Chen, J., Guo, J., Cui, X., et al. (2018) The Long Noncoding RNA LnRPT Is Regulated by PDGF-BB and Modulates the Proliferation of Pulmonary Artery Smooth Muscle Cells. American Journal of Respiratory Cell and Molecular Biology, 58, 181-193. https://doi.org/10.1165/rcmb.2017-0111OC
|
[39]
|
Juan, V., Crain, C. and Wilson, C. (2000) Evidence for Evolutionarily Conserved Secondary Structure in the H19 Tumor Suppressor RNA. Nucleic Acids Research, 28, 1221-1227. https://doi.org/10.1093/nar/28.5.1221
|
[40]
|
Cai, X. and Cullen, B.R. (2007) The Imprinted H19 Noncoding RNA Is a Primary microRNA Precursor. RNA, 13, 313-316. https://doi.org/10.1261/rna.351707
|
[41]
|
Huang, S.F., Zhao, G., Peng, X.F., et al. (2021) The Pathogenic Role of Long Non-Coding RNA H19 in Atherosclerosis via the miR-146a-5p/ANGPTL4 Pathway. Frontiers in Cardiovascular Medicine, 8, Article ID: 770163.
https://doi.org/10.3389/fcvm.2021.770163
|
[42]
|
Pan, J.X. (2017) LncRNA H19 Promotes Atherosclerosis by Regulating MAPK and NF-kB Signaling Pathway. European Review for Medical and Pharmacological Sciences, 21, 322-328.
|
[43]
|
Kallen, A.N., Zhou, X.B., Xu, J., et al. (2013) The Imprinted H19 lncRNA Antagonizes let-7 microRNAs. Molecular Cell, 52, 101-112. https://doi.org/10.1016/j.molcel.2013.08.027
|
[44]
|
Su, H., Xu, X., Yan, C., et al. (2018) LncRNA H19 Promotes the Proliferation of Pulmonary Artery Smooth Muscle Cells through AT1R via Sponging let-7b in Monocrotaline-Induced Pulmonary Arterial Hypertension. Respiratory Research, 19, Article No. 254. https://doi.org/10.1186/s12931-018-0956-z
|
[45]
|
Wang, R., Zhou, S., Wu, P., et al. (2018) Identifying Involvement of H19-miR-675-3p-IGF1R and H19-miR-200a-PDCD4 in Treating Pulmonary Hypertension with Melatonin. Molecular Therapy Nucleic Acids, 13, 44-54.
https://doi.org/10.1016/j.omtn.2018.08.015
|
[46]
|
Omura, J., Habbout, K., Shimauchi, T., et al. (2020) Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension. Circulation, 142, 1464-1484.
https://doi.org/10.1161/CIRCULATIONAHA.120.047626
|
[47]
|
Yang, L., Liang, H., Shen, L., et al. (2019) LncRNA Tug1 Involves in the Pulmonary Vascular Remodeling in Mice with Hypoxic Pulmonary Hypertension via the microRNA-374c-Mediated Foxc1. Life Sciences, 237, Article ID: 116769.
https://doi.org/10.1016/j.lfs.2019.116769
|
[48]
|
Zhang, H., Liu, Y., Yan, L., et al. (2019) Long Noncoding RNA Hoxaas3 Contributes to Hypoxia-Induced Pulmonary Artery Smooth Muscle Cell Proliferation. Cardiovascular Research, 115, 647-657. https://doi.org/10.1093/cvr/cvy250
|
[49]
|
Sun, Z., Nie, X., Sun, S., et al. (2017) Long Non-Coding RNA MEG3 Downregulation Triggers Human Pulmonary Artery Smooth Muscle Cell Proliferation and Migration via the p53 Signaling Pathway. Cellular Physiology and Biochemistry, 42, 2569-2581. https://doi.org/10.1159/000480218
|
[50]
|
Zhu, B., Gong, Y., Yan, G., et al. (2018) Down-Regulation of lncRNA MEG3 Promotes Hypoxia-Induced Human Pulmonary Artery Smooth Muscle Cell Proliferation and Migration via Repressing PTEN by Sponging miR-21. Biochemical and Biophysical Research Communications, 495, 2125-2132. https://doi.org/10.1016/j.bbrc.2017.11.185
|
[51]
|
Xing, Y., Zheng, X., Fu, Y., et al. (2019) Long Noncoding RNA-Maternally Expressed Gene 3 Contributes to Hypoxic Pulmonary Hypertension. Molecular Therapy, 27, 2166-2181. https://doi.org/10.1016/j.ymthe.2019.07.022
|
[52]
|
Zhang, X., Hamblin, M.H. and Yin, K.J. (2017) The Long Noncoding RNA Malat1: Its Physiological and Pathophysiological Functions. RNA Biology, 14, 1705-1714. https://doi.org/10.1080/15476286.2017.1358347
|
[53]
|
Brock, M., Schuoler, C., Leuenberger, C., et al. (2017) Analysis of Hypoxia-Induced Noncoding RNAs Reveals Metastasis-Associated Lung Adenocarcinoma Transcript 1 as an Important Regulator of Vascular Smooth Muscle Cell Proliferation. Experimental Biology and Medicine (Maywood), 242, 487-496.
https://doi.org/10.1177/1535370216685434
|
[54]
|
Zhuo, Y., Zeng, Q., Zhang, P., et al. (2017) Functional Polymorphism of lncRNA MALAT1 Contributes to Pulmonary Arterial Hypertension Susceptibility in Chinese People. Clinical Chemistry and Laboratory Medicine, 55, 38-46.
https://doi.org/10.1515/cclm-2016-0056
|
[55]
|
He, M., Shen, J., Zhang, C., et al. (2020) Long-Chain Non-Coding RNA Metastasis-Related Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes the Proliferation and Migration of Human Pulmonary Artery Smooth Muscle Cells (hPASMCs) by Regulating the MicroRNA-503 (miR-503)/Toll-Like Receptor 4 (TLR4) Signal Axis. Medical Science Monitor, 26, e923123. https://doi.org/10.12659/MSM.923123
|
[56]
|
Zhou, H., Sun, L. and Wan, F. (2019) Molecular Mechanisms of TUG1 in the Proliferation, Apoptosis, Migration and Invasion of Cancer Cells. Oncology Letters, 18, 4393-4402. https://doi.org/10.3892/ol.2019.10848
|
[57]
|
Wang, S., Cao, W., Gao, S., et al. (2019) TUG1 Regulates Pulmonary Arterial Smooth Muscle Cell Proliferation in Pulmonary Arterial Hypertension. Canadian Journal of Cardiology, 35, 1534-1545.
https://doi.org/10.1016/j.cjca.2019.07.630
|
[58]
|
Yao, Q., Wang, C., Wang, Y., et al. (2022) The Integrated Comprehension of lncRNA HOXA-AS3 Implication on Human Diseases. Clinical and Translational Oncology, 24, 2342-2350. https://doi.org/10.1007/s12094-022-02920-w
|
[59]
|
Li, Z.K., Gao, L.F., Zhu, X.A., et al. (2021) LncRNA HOXA-AS3 Promotes the Progression of Pulmonary Arterial Hypertension through Mediation of miR-675-3p/PDE5A Axis. Biochemical Genetics, 59, 1158-1172.
https://doi.org/10.1007/s10528-021-10053-y
|
[60]
|
Zehendner, C.M., Valasarajan, C., Werner, A., et al. (2020) Long Noncoding RNA TYKRIL Plays a Role in Pulmonary Hypertension via the p53-mediated Regulation of PDGFRβ. American Journal of Respiratory and Critical Care Medicine, 202, 1445-1457. https://doi.org/10.1164/rccm.201910-2041OC
|
[61]
|
Wang, F., Li, X., Xie, X., et al. (2008) UCA1, a Non-Protein-Coding RNA Up-Regulated in Bladder Carcinoma and Embryo, Influencing Cell Growth and Promoting Invasion. FEBS Letters, 582, 1919-1927.
https://doi.org/10.1016/j.febslet.2008.05.012
|
[62]
|
He, A., Hu, R., Chen, Z., et al. (2017) Role of Long Noncoding RNA UCA1 as a Common Molecular Marker for Lymph Node Metastasis and Prognosis in Various Cancers: A Meta-Analysis. Oncotarget, 8, 1937-1943.
https://doi.org/10.18632/oncotarget.12463
|
[63]
|
Zhu, T.T., Sun, R.L., Yin, Y.L., et al. (2019) Long Noncoding RNA UCA1 Promotes the Proliferation of Hypoxic Human Pulmonary Artery Smooth Muscle Cells. Pflügers Archiv, 471, 347-355.
https://doi.org/10.1007/s00424-018-2219-8
|
[64]
|
Lei, S., Peng, F., Li, M.L., et al. (2020) LncRNA-SMILR Modulates RhoA/ROCK Signaling by Targeting miR-141 to Regulate Vascular Remodeling in Pulmonary Arterial Hypertension. The American Journal of Physiology-Heart and Circulatory Physiology, 319, H377-H391. https://doi.org/10.1152/ajpheart.00717.2019
|
[65]
|
Ballantyne, M.D., Pinel, K., Dakin, R., et al. (2016) Smooth Muscle Enriched Long Noncoding RNA (SMILR) Regulates Cell Proliferation. Circulation, 133, 2050-2065. https://doi.org/10.1161/CIRCULATIONAHA.115.021019
|
[66]
|
Mahmoud, A.D., Ballantyne, M.D., Miscianinov, V., et al. (2019) The Human-Specific and Smooth Muscle Cell-Enriched LncRNA SMILR Promotes Proliferation by Regulating Mitotic CENPF mRNA and Drives Cell-Cycle Progression Which Can Be Targeted to Limit Vascular Remodeling. Circulation Research, 125, 535-551.
https://doi.org/10.1161/CIRCRESAHA.119.314876
|
[67]
|
Carpenter, S., Aiello, D., Atianand, M.K., et al. (2013) A Long Noncoding RNA Mediates both Activation and Repression of Immune Response Genes. Science, 341, 789-792. https://doi.org/10.1126/science.1240925
|
[68]
|
Xue, Z., Zhang, Z., Liu, H., et al. (2019) lincRNA-Cox2 Regulates NLRP3 Inflammasome and Autophagy Mediated Neuroinflammation. Cell Death & Differentiation, 26, 130-145. https://doi.org/10.1038/s41418-018-0105-8
|
[69]
|
Cheng, G., He, L. and Zhang, Y. (2020) LincRNA-Cox2 Promotes Pulmonary Arterial Hypertension by Regulating the let-7a-Mediated STAT3 Signaling Pathway. Molecular and Cellular Biochemistry, 475, 239-247.
https://doi.org/10.1007/s11010-020-03877-6
|
[70]
|
Leung, A., Trac, C., Jin, W., et al. (2013) Novel Long Noncoding RNAs Are Regulated by Angiotensin II in Vascular Smooth Muscle Cells. Circulation Research, 113, 266-278. https://doi.org/10.1161/CIRCRESAHA.112.300849
|
[71]
|
Nie, X., Chen, Y., Tan, J., et al. (2019) MicroRNA-221-3p Promotes Pulmonary Artery Smooth Muscle Cells Proliferation by Targeting AXIN2 during Pulmonary Arterial Hypertension. Vascular Pharmacology, 116, 24-35.
https://doi.org/10.1016/j.vph.2017.07.002
|
[72]
|
Wang, H., Qin, R. and Cheng, Y. (2020) LncRNA-Ang362 Promotes Pulmonary Arterial Hypertension by Regulating miR-221 and miR-222. Shock, 53, 723-729. https://doi.org/10.1097/SHK.0000000000001410
|
[73]
|
Jandl, K., Thekkekara Puthenparampil, H., Marsh, L.M., et al. (2019) Long Non-Coding RNAs Influence the Transcriptome in Pulmonary Arterial Hypertension: The Role of PAXIP1-AS1. The Journal of Pathology, 247, 357-370.
https://doi.org/10.1002/path.5195
|
[74]
|
Song, R., Lei, S., Yang, S., et al. (2021) LncRNA PAXIP1-AS1 Fosters the Pathogenesis of Pulmonary Arterial Hypertension via ETS1/WIPF1/RhoA Axis. Journal of Cellular and Molecular Medicine, 25, 7321-7334.
https://doi.org/10.1111/jcmm.16761
|
[75]
|
Qin, Y., Zhu, B., Li, L., et al. (2021) Overexpressed lncRNA AC068039.4 Contributes to Proliferation and Cell Cycle Progression of Pulmonary Artery Smooth Muscle Cells via Sponging miR-26a-5p/TRPC6 in Hypoxic Pulmonary Arterial Hypertension. Shock, 55, 244-255. https://doi.org/10.1097/SHK.0000000000001606
|
[76]
|
Wang, L., Han, S., Jin, G., et al. (2014) Linc00963: A Novel, Long Non-Coding RNA Involved in the Transition of Prostate Cancer from Androgen-Dependence to Androgen-Independence. International Journal of Oncology, 44, 2041-2049.
https://doi.org/10.3892/ijo.2014.2363
|
[77]
|
Xie, Z., Zhong, C., Shen, J., et al. (2022) LINC00963: A Potential Cancer Diagnostic and Therapeutic Target. Biomedicine & Pharmacotherapy, 150, Article ID: 113019. https://doi.org/10.1016/j.biopha.2022.113019
|
[78]
|
Yang, C., Rong, R., Li, Y., et al. (2022) Decrease in LINC00963 Attenuates the Progression of Pulmonary Arterial Hypertension via microRNA-328-3p/Profilin 1 Axis. Journal of Clinical Laboratory Analysis, 36, e24383.
https://doi.org/10.1002/jcla.24383
|
[79]
|
Huppi, K., Volfovsky, N., Runfola, T., et al. (2008) The Identification of microRNAs in a Genomically Unstable Region of Human Chromosome 8q24. Molecular Cancer Research, 6, 212-221.
https://doi.org/10.1158/1541-7786.MCR-07-0105
|
[80]
|
Jin, K., Wang, S., Zhang, Y., et al. (2019) Long Non-Coding RNA PVT1 Interacts with MYC and Its Downstream Molecules to Synergistically Promote Tumorigenesis. Cellular and Molecular Life Sciences, 76, 4275-4289.
https://doi.org/10.1007/s00018-019-03222-1
|
[81]
|
Xia, X., Huang, L., Zhou, S., et al. (2023) Hypoxia-Induced Long Non-Coding RNA Plasmacytoma Variant Translocation 1 Upregulation Aggravates Pulmonary Arterial Smooth Muscle Cell Proliferation by Regulating Autophagy via miR-186/Srf/Ctgf and miR-26b/Ctgf Signaling Pathways. International Journal of Cardiology, 370, 368-377.
https://doi.org/10.1016/j.ijcard.2022.09.060
|
[82]
|
Yu, X., Li, Z., Zheng, H., et al. (2017) NEAT1: A Novel Cancer-Related Long Non-Coding RNA. Cell Proliferation, 50, e12329. https://doi.org/10.1111/cpr.12329
|
[83]
|
Dou, X., Ma, Y., Qin, Y., et al. (2021) NEAT1 Silencing Alleviates Pulmonary Arterial Smooth Muscle Cell Migration and Proliferation under Hypoxia through Regulation of miR‑34a‑5p/KLF4 in Vitro. Molecular Medicine Reports, 24, Article No. 749. https://doi.org/10.3892/mmr.2021.12389
|
[84]
|
Wu, Z.H., Zhou, J., Hu, G.H., et al. (2021) LncRNA CASC2 Inhibits Lung Adenocarcinoma Progression through Forming Feedback Loop with miR-21/p53 Axis. The Kaohsiung Journal of Medical Sciences, 37, 675-685.
https://doi.org/10.1002/kjm2.12386
|
[85]
|
Gong, J., Chen, Z., Chen, Y., et al. (2019) Long Non-Coding RNA CASC2 Suppresses Pulmonary Artery Smooth Muscle Cell Proliferation and Phenotypic Switch in Hypoxia-Induced Pulmonary Hypertension. Respiratory Research, 20, Article No. 53. https://doi.org/10.1186/s12931-019-1018-x
|
[86]
|
Han, Y., Liu, Y., Yang, C., et al. (2020) LncRNA CASC2 Inhibits Hypoxia-Induced Pulmonary Artery Smooth Muscle Cell Proliferation and Migration by Regulating the miR-222/ING5 Axis. Cell & Molecular Bio Letters, 25, Article No. 21. https://doi.org/10.1186/s11658-020-00215-y
|
[87]
|
Liu, Y., Hu, R., Zhu, J., et al. (2021) The lncRNA PAHRF Functions as a Competing Endogenous RNA to Regulate MST1 Expression by Sponging miR-23a-3p in Pulmonary Arterial Hypertension. Vascular Pharmacology, 139, Article ID: 106886. https://doi.org/10.1016/j.vph.2021.106886
|
[88]
|
Kino, T., Hurt, D.E., Ichijo, T., Nader, N. and Chrousos, G.P. (2010) Noncoding RNA gas5 Is a Growth Arrest and Starvation-Associated Repressor of the Glucocorticoid Receptor. Science Signaling, 3, ra8.
https://doi.org/10.1126/scisignal.2000568
|
[89]
|
Gao, Z.Q., Wang, J.F., Chen, D.H., et al. (2017) Long Non-Coding RNA GAS5 Suppresses Pancreatic Cancer Metastasis through Modulating miR-32-5p/PTEN Axis. Cell & Bioscience, 7, Article No. 66.
https://doi.org/10.1186/s13578-017-0192-0
|
[90]
|
Li, Y., Gu, J. and Lu, H. (2017) The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells through the PTEN/Akt/mTOR Pathway. Digestive Diseases and Sciences, 62, 3426-3437.
https://doi.org/10.1007/s10620-017-4831-4
|
[91]
|
Tang, R., Zhang, G., Wang, Y.C., et al. (2017) The Long Non-Coding RNA GAS5 Regulates Transforming Growth Factor β (TGF-β)-Induced Smooth Muscle Cell Differentiation via RNA Smad-Binding Elements. Journal of Biological Chemistry, 292, 14270-14278. https://doi.org/10.1074/jbc.M117.790030
|
[92]
|
Hao, X., Li, H., Zhang, P., et al. (2020) Down-Regulation of lncRNA Gas5 Promotes Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation by Regulating KCNK3 Expression. European Journal of Pharmacology, 889, Article ID: 173618. https://doi.org/10.1016/j.ejphar.2020.173618
|
[93]
|
Feng, X., Wang, K., Yang, T., et al. (2022) LncRNA-GAS5/miR-382-3p Axis Inhibits Pulmonary Artery Remodeling and Promotes Autophagy in Chronic Thromboembolic Pulmonary Hypertension. Genes Genomics, 44, 395-404.
https://doi.org/10.1007/s13258-021-01202-z
|
[94]
|
Liu, Y., Zhang, H., Li, Y., et al. (2020) Long Noncoding RNA Rps4l Mediates the Proliferation of Hypoxic Pulmonary Artery Smooth Muscle Cells. Hypertension, 76, 1124-1133. https://doi.org/10.1161/HYPERTENSIONAHA.120.14644
|
[95]
|
Li, Y., Zhang, J., Sun, H., et al. (2021) lnc-Rps4l-Encoded Peptide RPS4XL Regulates RPS6 Phosphorylation and Inhibits the Proliferation of PASMCs Caused by Hypoxia. Molecular Therapy, 29, 1411-1424.
https://doi.org/10.1016/j.ymthe.2021.01.005
|
[96]
|
Li, Y., Zhang, J., Sun, H., et al. (2022) RPS4XL Encoded by lnc-Rps4l Inhibits Hypoxia-Induced Pyroptosis by Binding HSC70 Glycosylation Site. Molecular Therapy Nucleic Acids, 28, 920-934.
https://doi.org/10.1016/j.omtn.2022.05.033
|
[97]
|
Liu, Y., Sun, Z., Zhu, J., et al. (2018) LncRNA-TCONS_00034812 in Cell Proliferation and Apoptosis of Pulmonary Artery Smooth Muscle Cells and Its Mechanism. Journal of Cellular Physiology, 233, 4801-4814.
https://doi.org/10.1002/jcp.26279
|
[98]
|
Lin, D., Zhang, X., Zhang, C., et al. (2021) LncRNA-TCONS_00034812 Is Upregulated in Atherosclerosis and Upregulates miR-21 through Methylation in Vascular Smooth Muscle Cells. Annals of Translational Medicine, 9, 1005.
https://doi.org/10.21037/atm-21-2632
|
[99]
|
Pasmant, E., Laurendeau, I., Héron, D., et al. (2007) Characterization of a Germ-Line Deletion, Including the Entire INK4/ARF Locus, in a Melanoma-Neural System Tumor Family: Identification of ANRIL, an Antisense Noncoding RNA Whose Expression Coclusters with ARF. Cancer Research, 67, 3963-3969.
https://doi.org/10.1158/0008-5472.CAN-06-2004
|
[100]
|
Chen, L., Qu, H., Guo, M., et al. (2020) ANRIL and Atherosclerosis. Journal of Clinical Pharmacy and Therapeutics, 45, 240-248. https://doi.org/10.1111/jcpt.13060
|
[101]
|
Wang, S., Zhang, C. and Zhang, X. (2020) Downregulation of Long Non‑Coding RNA ANRIL Promotes Proliferation and Migration in Hypoxic Human Pulmonary Artery Smooth Muscle Cells. Molecular Medicine Reports, 21, 589-596.
https://doi.org/10.3892/mmr.2019.10887
|
[102]
|
Deng, L., Chen, J., Chen, B., et al. (2022) LncPTSR Triggers Vascular Remodeling in Pulmonary Hypertension by Regulating [Ca2+]i in Pulmonary Arterial Smooth Muscle Cells. American Journal of Respiratory Cell and Molecular Biology, 66, 524-538. https://doi.org/10.1165/rcmb.2020-0480OC
|
[103]
|
Wu, G., Cai, J., Han, Y., et al. (2014) LincRNA-p21 Regulates Neointima Formation, Vascular Smooth Muscle Cell Proliferation, Apoptosis, and Atherosclerosis by Enhancing p53 Activity. Circulation, 130, 1452-1465.
https://doi.org/10.1161/CIRCULATIONAHA.114.011675
|
[104]
|
Wang, H., He, F., Liang, B., et al. (2021) p53-Dependent LincRNA-p21 Protects against Proliferation and Anti-Apoptosis of Vascular Smooth Muscle Cells in Atherosclerosis by Upregulating SIRT7 via MicroRNA-17-5p. Journal of Cardiovascular Translational Research, 14, 426-440. https://doi.org/10.1007/s12265-020-10074-9
|
[105]
|
Leisegang, M.S., Fork, C., Josipovic, I., et al. (2017) Long Noncoding RNA MANTIS Facilitates Endothelial Angiogenic Function. Circulation, 136, 65-79. https://doi.org/10.1161/CIRCULATIONAHA.116.026991
|
[106]
|
Wu, Q., Zhou, X., Wang, Y., et al. (2022) LncRNA GAS5 Promotes Spermidine-Induced Autophagy through the miRNA-31-5p/NAT8L Axis in Pulmonary Artery Endothelial Cells of Patients with CTEPH. Molecular Medicine Reports, 26, Article No. 297. https://doi.org/10.3892/mmr.2022.12813
|
[107]
|
Gofrit, O.N., Benjamin, S., Halachmi, S., et al. (2014) DNA Based Therapy with Diphtheria Toxin-A BC-819: A Phase 2b Marker Lesion Trial in Patients with Intermediate Risk Nonmuscle Invasive Bladder Cancer. Journal of Urology, 191, 1697-1702. https://doi.org/10.1016/j.juro.2013.12.011
|
[108]
|
Smaldone, M.C. and Davies, B.J. (2010) BC-819, a Plasmid Comprising the H19 Gene Regulatory Sequences and Diphtheria Toxin A, for the Potential Targeted Therapy of Cancers. Current Opinion in Molecular Therapeutics, 12, 607-616.
|
[109]
|
Gomes, C.P.C., Spencer, H., Ford, K.L., et al. (2017) The Function and Therapeutic Potential of Long Non-Coding RNAs in Cardiovascular Development and Disease. Molecular Therapy Nucleic Acids, 8, 494-507.
https://doi.org/10.1016/j.omtn.2017.07.014
|
[110]
|
Hassoun, P.M. (2021) Pulmonary Arterial Hypertension. The New England Journal of Medicine, 385, 2361-2376.
https://doi.org/10.1056/NEJMra2000348
|
[111]
|
Ruopp, N.F. and Cockrill, B.A. (2022) Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review. JAMA, 327, 1379-1391. https://doi.org/10.1001/jama.2022.4402
|
[112]
|
Han, B., Bu, P., Meng, X., et al. (2017) Microarray Profiling of Long Non-Coding RNAs Associated with Idiopathic Pulmonary Arterial Hypertension. Experimental and Therapeutic Medicine, 13, 2657-2666.
https://doi.org/10.3892/etm.2017.4355
|
[113]
|
Okazaki, Y., Furuno, M., Kasukawa, T., et al. (2002) Analysis of the Mouse Transcriptome Based on Functional Annotation of 60,770 Full-Length cDNAs. Nature, 420, 563-73. https://doi.org/10.1038/nature01266
|
[114]
|
Mattick, J.S. and Makunin, I.V. (2006) Non-Coding RNA. Human Molecular Genetics, 15, R17-R29.
https://doi.org/10.1093/hmg/ddl046
|
[115]
|
Han, Y., Ali, M.K., Dua, K., et al. (2021) Role of Long Non-Coding RNAs in Pulmonary Arterial Hypertension. Cell, 10, Article No. 1892. https://doi.org/10.3390/cells10081892
|
[116]
|
Mercer, T.R., Dinger, M.E. and Mattick, J.S. (2009) Long Non-Coding RNAs: Insights into Functions. Human Molecular Genetics, 10, 155-159. https://doi.org/10.1038/nrg2521
|
[117]
|
Beermann, J., Piccoli, M.T., Viereck, J., et al. (2016) Non-Coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches. Physiological Reviews, 96, 1297-1325.
https://doi.org/10.1152/physrev.00041.2015
|
[118]
|
Sun, M., Nie, F., Wang, Y., et al. (2016) LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT. Cancer Research, 76, 6299-6310.
https://doi.org/10.1158/0008-5472.CAN-16-0356
|
[119]
|
Gasri-Plotnitsky, L., Ovadia, A., Shamalov, K., et al. (2017) A Novel lncRNA, GASL1, Inhibits Cell Proliferation and Restricts E2F1 Activity. Oncotarget, 8, 23775-23786. https://doi.org/10.18632/oncotarget.15864
|
[120]
|
Peng, W.X., Koirala, P. and Mo, Y.Y. (2017) LncRNA-Mediated Regulation of Cell Signaling in Cancer. Oncogene, 36, 5661-5667. https://doi.org/10.1038/onc.2017.184
|
[121]
|
Leeper, N.J. and Maegdefessel, L. (2018) Non-Coding RNAs: Key Regulators of Smooth Muscle Cell Fate in Vascular Disease. Cardiovascular Research, 114, 611-621. https://doi.org/10.1093/cvr/cvx249
|
[122]
|
Haemmig, S., Simion, V. and Feinberg, M.W. (2018) Long Non-Coding RNAs in Vascular Inflammation. Frontiers in Cardiovascular Medicine, 5, Article No. 22. https://doi.org/10.3389/fcvm.2018.00022
|
[123]
|
Leimena, C. and Qiu, H. (2018) Non-Coding RNA in the Pathogenesis, Progression and Treatment of Hypertension. International Journal of Molecular Sciences, 19, Article No. 927. https://doi.org/10.3390/ijms19040927
|
[124]
|
Chi, Y., Wang, D., Wang, J., et al. (2019) Long Non-Coding RNA in the Pathogenesis of Cancers. Cells, 8, Article No. 1015. https://doi.org/10.3390/cells8091015
|
[125]
|
Simion, V., Haemmig, S. and Feinberg, M.W. (2019) LncRNAs in Vascular Biology and Disease. Vascular Pharmacology, 114, 145-156. https://doi.org/10.1016/j.vph.2018.01.003
|
[126]
|
Wolowiec, L., Medlewska, M., Osiak, J., et al. (2023) MicroRNA and lncRNA as the Future of Pulmonary Arterial Hypertension Treatment. International Journal of Molecular Sciences, 24, Article No. 9735.
https://doi.org/10.3390/ijms24119735
|
[127]
|
WKovacs, G., Dumitrescu, D., Barner, A., et al. (2018) Definition, Clinical Classification and Initial Diagnosis of Pulmonary Hypertension: Updated Recommendations from the Cologne Consensus Conference 2018. International Journal of Cardiology, 272S, 11-19. https://doi.org/10.1016/j.ijcard.2018.08.083
|
[128]
|
Vaillancourt, M., Ruffenach, G., Meloche, J., et al. (2015) Adaptation and Remodelling of the Pulmonary Circulation in Pulmonary Hypertension. Canadian Journal of Cardiology, 31, 407-415. https://doi.org/10.1016/j.cjca.2014.10.023
|
[129]
|
Sommer, N., Ghofrani, H.A., Pak, O., et al. (2021) Current and Future Treatments of Pulmonary Arterial Hypertension. British Journal of Pharmacology, 178, 6-30. https://doi.org/10.1111/bph.15016
|
[130]
|
Leopold, J.A. and Maron, B.A. (2016) Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension. International Journal of Molecular Sciences, 17, Article No. 761.
https://doi.org/10.3390/ijms17050761
|
[131]
|
Price, L.C., Wort, S.J., Perros, F., et al. (2012) Inflammation in Pulmonary Arterial Hypertension. Chest, 141, 210-221.
https://doi.org/10.1378/chest.11-0793
|
[132]
|
Nogueira-Ferreira, R., Vitorino, R., Ferreira, R., et al. (2015) Exploring the Monocrotaline Animal Model for the Study of Pulmonary Arterial Hypertension: A Network Approach. Pulmonary Pharmacology & Therapeutics, 35, 8-16.
https://doi.org/10.1016/j.pupt.2015.09.007
|
[133]
|
Rieg, A.D., Suleiman, S., Anker, C., et al. (2018) PDGF-BB Regulates the Pulmonary Vascular Tone: Impact of Prostaglandins, Calcium, MAPK- and PI3K/AKT/mTOR Signalling and Actin Polymerisation in Pulmonary Veins of Guinea Pigs. Respiratory Research, 19, Article No. 120. https://doi.org/10.1186/s12931-018-0829-5
|
[134]
|
Qian, Z., Li, Y., Chen, J., et al. (2017) miR-4632 Mediates PDGF-BB-Induced Proliferation and Antiapoptosis of Human Pulmonary Artery Smooth Muscle Cells via Targeting cJUN. American Journal of Physiology-Cell Physiology, 313, C380-C391. https://doi.org/10.1152/ajpcell.00061.2017
|
[135]
|
Tan, W.S.D., Liao, W., Zhou, S., et al. (2018) Targeting the Renin-Angiotensin System as Novel Therapeutic Strategy for Pulmonary Diseases. Current Opinion in Pharmacology, 40, 9-17. https://doi.org/10.1016/j.coph.2017.12.002
|
[136]
|
Viswanathan, G., Mamazhakypov, A., Schermuly, R.T., et al. (2018) The Role of G Protein-Coupled Receptors in the Right Ventricle in Pulmonary Hypertension. Frontiers in Cardiovascular Medicine, 5, Article No. 179.
https://doi.org/10.3389/fcvm.2018.00179
|
[137]
|
De Man, F.S., Tu, L., Handoko, M.L., et al. (2012) Dysregulated Renin-Angiotensin-Aldosterone System Contributes to Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine, 186, 780-790.
https://doi.org/10.1164/rccm.201203-0411OC
|
[138]
|
Gupta, V.S. and Harting, M.T. (2020) Congenital Diaphragmatic Hernia-Associated Pulmonary Hypertension. Seminars in Perinatology, 44, Article ID: 151167. https://doi.org/10.1053/j.semperi.2019.07.006
|
[139]
|
Longoni, M., Russell, M.K., High, F.A., et al. (2015) Prevalence and Penetrance of ZFPM2 Mutations and Deletions Causing Congenital Diaphragmatic Hernia. Clinical Genetics, 87, 362-367. https://doi.org/10.1111/cge.12395
|
[140]
|
McCulley, D.J., Wienhold, M.D., Hines, E.A., et al. (2018) PBX Transcription Factors Drive Pulmonary Vascular Adaptation to Birth. Journal of Clinical Investigation, 128, 655-667. https://doi.org/10.1172/JCI93395
|
[141]
|
Cao, Y., Yang, Y., Wang, L., et al. (2018) Analyses of Long Non-Coding RNA and mRNA Profiles in Right Ventricle Myocardium of Acute Right Heart Failure in Pulmonary Arterial Hypertension Rats. Biomedicine & Pharmacotherapy, 106, 1108-1115. https://doi.org/10.1016/j.biopha.2018.07.057
|
[142]
|
Zahid, K.R., Raza, U., Chen, J., et al. (2020) Pathobiology of Pulmonary Artery Hypertension: Role of Long Non-Coding RNAs. Cardiovascular Research, 116, 1937-1947. https://doi.org/10.1093/cvr/cvaa050
|
[143]
|
Awad, K.S., West, J.D., de Jesus Perez, V., et al. (2016) Novel Signaling Pathways in Pulmonary Arterial Hypertension (2015 Grover Conference Series). Pulmonary Circulation, 6, 285-294. https://doi.org/10.1086/688034
|
[144]
|
Wilson, J.L., Yu, J., Taylor, L., et al. (2015) Hyperplastic Growth of Pulmonary Artery Smooth Muscle Cells from Subjects with Pulmonary Arterial Hypertension Is Activated through JNK and p38 MAPK. PLOS ONE, 14, e0123662.
https://doi.org/10.1371/journal.pone.0123662
|
[145]
|
Wang, J., Feng, W., Li, F., et al. (2019) SphK1/S1P Mediates TGF-β1-Induced Proliferation of Pulmonary Artery Smooth Muscle Cells and Its Potential Mechanisms. Pulmonary Circulation, 9, 1-8.
https://doi.org/10.1177/2045894018816977
|
[146]
|
Wang, D., Xu, H., Wu, B., et al. (2019) Long Non‑Coding RNA MALAT1 Sponges miR‑124‑3p.1/KLF5 to Promote Pulmonary Vascular Remodeling and Cell Cycle Progression of Pulmonary Artery Hypertension. International Journal of Molecular Medicine, 44, 871-884. https://doi.org/10.3892/ijmm.2019.4256
|
[147]
|
Chen, J., Guo, J., Cui, X., et al. (2018) The Long Noncoding RNA LnRPT Is Regulated by PDGF-BB and Modulates the Proliferation of Pulmonary Artery Smooth Muscle Cells. American Journal of Respiratory Cell and Molecular Biology, 58, 181-193. https://doi.org/10.1165/rcmb.2017-0111OC
|
[148]
|
Juan, V., Crain, C. and Wilson, C. (2000) Evidence for Evolutionarily Conserved Secondary Structure in the H19 Tumor Suppressor RNA. Nucleic Acids Research, 28, 1221-1227. https://doi.org/10.1093/nar/28.5.1221
|
[149]
|
Cai, X. and Cullen, B.R. (2007) The Imprinted H19 Noncoding RNA Is a Primary microRNA Precursor. RNA, 13, 313-316. https://doi.org/10.1261/rna.351707
|
[150]
|
Huang, S.F., Zhao, G., Peng, X.F., et al. (2021) The Pathogenic Role of Long Non-Coding RNA H19 in Atherosclerosis via the miR-146a-5p/ANGPTL4 Pathway. Frontiers in Cardiovascular Medicine, 8, Article ID: 770163.
https://doi.org/10.3389/fcvm.2021.770163
|
[151]
|
Pan, J.X. (2017) LncRNA H19 Promotes Atherosclerosis by Regulating MAPK and NF-kB Signaling Pathway. European Review for Medical and Pharmacological Sciences, 21, 322-328.
|
[152]
|
Kallen, A.N., Zhou, X.B., Xu, J., et al. (2013) The Imprinted H19 lncRNA Antagonizes let-7 microRNAs. Molecular Cell, 52, 101-112. https://doi.org/10.1016/j.molcel.2013.08.027
|
[153]
|
Su, H., Xu, X., Yan, C., et al. (2018) LncRNA H19 Promotes the Proliferation of Pulmonary Artery Smooth Muscle Cells through AT1R via Sponging let-7b in Monocrotaline-Induced Pulmonary Arterial Hypertension. Respiratory Research, 19, Article No. 254. https://doi.org/10.1186/s12931-018-0956-z
|
[154]
|
Wang, R., Zhou, S., Wu, P., et al. (2018) Identifying Involvement of H19-miR-675-3p-IGF1R and H19-miR-200a-PDCD4 in Treating Pulmonary Hypertension with Melatonin. Molecular Therapy Nucleic Acids, 13, 44-54.
https://doi.org/10.1016/j.omtn.2018.08.015
|
[155]
|
Omura, J., Habbout, K., Shimauchi, T., et al. (2020) Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension. Circulation, 142, 1464-1484.
https://doi.org/10.1161/CIRCULATIONAHA.120.047626
|
[156]
|
Yang, L., Liang, H., Shen, L., et al. (2019) LncRNA Tug1 Involves in the Pulmonary Vascular Remodeling in Mice with Hypoxic Pulmonary Hypertension via the microRNA-374c-Mediated Foxc1. Life Sciences, 237, Article ID: 116769.
https://doi.org/10.1016/j.lfs.2019.116769
|
[157]
|
Zhang, H., Liu, Y., Yan, L., et al. (2019) Long Noncoding RNA Hoxaas3 Contributes to Hypoxia-Induced Pulmonary Artery Smooth Muscle Cell Proliferation. Cardiovascular Research, 115, 647-657. https://doi.org/10.1093/cvr/cvy250
|
[158]
|
Sun, Z., Nie, X., Sun, S., et al. (2017) Long Non-Coding RNA MEG3 Downregulation Triggers Human Pulmonary Artery Smooth Muscle Cell Proliferation and Migration via the p53 Signaling Pathway. Cellular Physiology and Biochemistry, 42, 2569-2581. https://doi.org/10.1159/000480218
|
[159]
|
Zhu, B., Gong, Y., Yan, G., et al. (2018) Down-Regulation of lncRNA MEG3 Promotes Hypoxia-Induced Human Pulmonary Artery Smooth Muscle Cell Proliferation and Migration via Repressing PTEN by Sponging miR-21. Biochemical and Biophysical Research Communications, 495, 2125-2132. https://doi.org/10.1016/j.bbrc.2017.11.185
|
[160]
|
Xing, Y., Zheng, X., Fu, Y., et al. (2019) Long Noncoding RNA-Maternally Expressed Gene 3 Contributes to Hypoxic Pulmonary Hypertension. Molecular Therapy, 27, 2166-2181. https://doi.org/10.1016/j.ymthe.2019.07.022
|
[161]
|
Zhang, X., Hamblin, M.H. and Yin, K.J. (2017) The Long Noncoding RNA Malat1: Its Physiological and Pathophysiological Functions. RNA Biology, 14, 1705-1714. https://doi.org/10.1080/15476286.2017.1358347
|
[162]
|
Brock, M., Schuoler, C., Leuenberger, C., et al. (2017) Analysis of Hypoxia-Induced Noncoding RNAs Reveals Metastasis-Associated Lung Adenocarcinoma Transcript 1 as an Important Regulator of Vascular Smooth Muscle Cell Proliferation. Experimental Biology and Medicine (Maywood), 242, 487-496.
https://doi.org/10.1177/1535370216685434
|
[163]
|
Zhuo, Y., Zeng, Q., Zhang, P., et al. (2017) Functional Polymorphism of lncRNA MALAT1 Contributes to Pulmonary Arterial Hypertension Susceptibility in Chinese People. Clinical Chemistry and Laboratory Medicine, 55, 38-46.
https://doi.org/10.1515/cclm-2016-0056
|
[164]
|
He, M., Shen, J., Zhang, C., et al. (2020) Long-Chain Non-Coding RNA Metastasis-Related Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes the Proliferation and Migration of Human Pulmonary Artery Smooth Muscle Cells (hPASMCs) by Regulating the MicroRNA-503 (miR-503)/Toll-Like Receptor 4 (TLR4) Signal Axis. Medical Science Monitor, 26, e923123. https://doi.org/10.12659/MSM.923123
|
[165]
|
Zhou, H., Sun, L. and Wan, F. (2019) Molecular Mechanisms of TUG1 in the Proliferation, Apoptosis, Migration and Invasion of Cancer Cells. Oncology Letters, 18, 4393-4402. https://doi.org/10.3892/ol.2019.10848
|
[166]
|
Wang, S., Cao, W., Gao, S., et al. (2019) TUG1 Regulates Pulmonary Arterial Smooth Muscle Cell Proliferation in Pulmonary Arterial Hypertension. Canadian Journal of Cardiology, 35, 1534-1545.
https://doi.org/10.1016/j.cjca.2019.07.630
|
[167]
|
Yao, Q., Wang, C., Wang, Y., et al. (2022) The Integrated Comprehension of lncRNA HOXA-AS3 Implication on Human Diseases. Clinical and Translational Oncology, 24, 2342-2350. https://doi.org/10.1007/s12094-022-02920-w
|
[168]
|
Li, Z.K., Gao, L.F., Zhu, X.A., et al. (2021) LncRNA HOXA-AS3 Promotes the Progression of Pulmonary Arterial Hypertension through Mediation of miR-675-3p/PDE5A Axis. Biochemical Genetics, 59, 1158-1172.
https://doi.org/10.1007/s10528-021-10053-y
|
[169]
|
Zehendner, C.M., Valasarajan, C., Werner, A., et al. (2020) Long Noncoding RNA TYKRIL Plays a Role in Pulmonary Hypertension via the p53-mediated Regulation of PDGFRβ. American Journal of Respiratory and Critical Care Medicine, 202, 1445-1457. https://doi.org/10.1164/rccm.201910-2041OC
|
[170]
|
Wang, F., Li, X., Xie, X., et al. (2008) UCA1, a Non-Protein-Coding RNA Up-Regulated in Bladder Carcinoma and Embryo, Influencing Cell Growth and Promoting Invasion. FEBS Letters, 582, 1919-1927.
https://doi.org/10.1016/j.febslet.2008.05.012
|
[171]
|
He, A., Hu, R., Chen, Z., et al. (2017) Role of Long Noncoding RNA UCA1 as a Common Molecular Marker for Lymph Node Metastasis and Prognosis in Various Cancers: A Meta-Analysis. Oncotarget, 8, 1937-1943.
https://doi.org/10.18632/oncotarget.12463
|
[172]
|
Zhu, T.T., Sun, R.L., Yin, Y.L., et al. (2019) Long Noncoding RNA UCA1 Promotes the Proliferation of Hypoxic Human Pulmonary Artery Smooth Muscle Cells. Pflügers Archiv, 471, 347-355.
https://doi.org/10.1007/s00424-018-2219-8
|
[173]
|
Lei, S., Peng, F., Li, M.L., et al. (2020) LncRNA-SMILR Modulates RhoA/ROCK Signaling by Targeting miR-141 to Regulate Vascular Remodeling in Pulmonary Arterial Hypertension. The American Journal of Physiology-Heart and Circulatory Physiology, 319, H377-H391. https://doi.org/10.1152/ajpheart.00717.2019
|
[174]
|
Ballantyne, M.D., Pinel, K., Dakin, R., et al. (2016) Smooth Muscle Enriched Long Noncoding RNA (SMILR) Regulates Cell Proliferation. Circulation, 133, 2050-2065. https://doi.org/10.1161/CIRCULATIONAHA.115.021019
|
[175]
|
Mahmoud, A.D., Ballantyne, M.D., Miscianinov, V., et al. (2019) The Human-Specific and Smooth Muscle Cell-Enriched LncRNA SMILR Promotes Proliferation by Regulating Mitotic CENPF mRNA and Drives Cell-Cycle Progression Which Can Be Targeted to Limit Vascular Remodeling. Circulation Research, 125, 535-551.
https://doi.org/10.1161/CIRCRESAHA.119.314876
|
[176]
|
Carpenter, S., Aiello, D., Atianand, M.K., et al. (2013) A Long Noncoding RNA Mediates both Activation and Repression of Immune Response Genes. Science, 341, 789-792. https://doi.org/10.1126/science.1240925
|
[177]
|
Xue, Z., Zhang, Z., Liu, H., et al. (2019) lincRNA-Cox2 Regulates NLRP3 Inflammasome and Autophagy Mediated Neuroinflammation. Cell Death & Differentiation, 26, 130-145. https://doi.org/10.1038/s41418-018-0105-8
|
[178]
|
Cheng, G., He, L. and Zhang, Y. (2020) LincRNA-Cox2 Promotes Pulmonary Arterial Hypertension by Regulating the let-7a-Mediated STAT3 Signaling Pathway. Molecular and Cellular Biochemistry, 475, 239-247.
https://doi.org/10.1007/s11010-020-03877-6
|
[179]
|
Leung, A., Trac, C., Jin, W., et al. (2013) Novel Long Noncoding RNAs Are Regulated by Angiotensin II in Vascular Smooth Muscle Cells. Circulation Research, 113, 266-278. https://doi.org/10.1161/CIRCRESAHA.112.300849
|
[180]
|
Nie, X., Chen, Y., Tan, J., et al. (2019) MicroRNA-221-3p Promotes Pulmonary Artery Smooth Muscle Cells Proliferation by Targeting AXIN2 during Pulmonary Arterial Hypertension. Vascular Pharmacology, 116, 24-35.
https://doi.org/10.1016/j.vph.2017.07.002
|
[181]
|
Wang, H., Qin, R. and Cheng, Y. (2020) LncRNA-Ang362 Promotes Pulmonary Arterial Hypertension by Regulating miR-221 and miR-222. Shock, 53, 723-729. https://doi.org/10.1097/SHK.0000000000001410
|
[182]
|
Jandl, K., Thekkekara Puthenparampil, H., Marsh, L.M., et al. (2019) Long Non-Coding RNAs Influence the Transcriptome in Pulmonary Arterial Hypertension: The Role of PAXIP1-AS1. The Journal of Pathology, 247, 357-370.
https://doi.org/10.1002/path.5195
|
[183]
|
Song, R., Lei, S., Yang, S., et al. (2021) LncRNA PAXIP1-AS1 Fosters the Pathogenesis of Pulmonary Arterial Hypertension via ETS1/WIPF1/RhoA Axis. Journal of Cellular and Molecular Medicine, 25, 7321-7334.
https://doi.org/10.1111/jcmm.16761
|
[184]
|
Qin, Y., Zhu, B., Li, L., et al. (2021) Overexpressed lncRNA AC068039.4 Contributes to Proliferation and Cell Cycle Progression of Pulmonary Artery Smooth Muscle Cells via Sponging miR-26a-5p/TRPC6 in Hypoxic Pulmonary Arterial Hypertension. Shock, 55, 244-255. https://doi.org/10.1097/SHK.0000000000001606
|
[185]
|
Wang, L., Han, S., Jin, G., et al. (2014) Linc00963: A Novel, Long Non-Coding RNA Involved in the Transition of Prostate Cancer from Androgen-Dependence to Androgen-Independence. International Journal of Oncology, 44, 2041-2049.
https://doi.org/10.3892/ijo.2014.2363
|
[186]
|
Xie, Z., Zhong, C., Shen, J., et al. (2022) LINC00963: A Potential Cancer Diagnostic and Therapeutic Target. Biomedicine & Pharmacotherapy, 150, Article ID: 113019. https://doi.org/10.1016/j.biopha.2022.113019
|
[187]
|
Yang, C., Rong, R., Li, Y., et al. (2022) Decrease in LINC00963 Attenuates the Progression of Pulmonary Arterial Hypertension via microRNA-328-3p/Profilin 1 Axis. Journal of Clinical Laboratory Analysis, 36, e24383.
https://doi.org/10.1002/jcla.24383
|
[188]
|
Huppi, K., Volfovsky, N., Runfola, T., et al. (2008) The Identification of microRNAs in a Genomically Unstable Region of Human Chromosome 8q24. Molecular Cancer Research, 6, 212-221.
https://doi.org/10.1158/1541-7786.MCR-07-0105
|
[189]
|
Jin, K., Wang, S., Zhang, Y., et al. (2019) Long Non-Coding RNA PVT1 Interacts with MYC and Its Downstream Molecules to Synergistically Promote Tumorigenesis. Cellular and Molecular Life Sciences, 76, 4275-4289.
https://doi.org/10.1007/s00018-019-03222-1
|
[190]
|
Xia, X., Huang, L., Zhou, S., et al. (2023) Hypoxia-Induced Long Non-Coding RNA Plasmacytoma Variant Translocation 1 Upregulation Aggravates Pulmonary Arterial Smooth Muscle Cell Proliferation by Regulating Autophagy via miR-186/Srf/Ctgf and miR-26b/Ctgf Signaling Pathways. International Journal of Cardiology, 370, 368-377.
https://doi.org/10.1016/j.ijcard.2022.09.060
|
[191]
|
Yu, X., Li, Z., Zheng, H., et al. (2017) NEAT1: A Novel Cancer-Related Long Non-Coding RNA. Cell Proliferation, 50, e12329. https://doi.org/10.1111/cpr.12329
|
[192]
|
Dou, X., Ma, Y., Qin, Y., et al. (2021) NEAT1 Silencing Alleviates Pulmonary Arterial Smooth Muscle Cell Migration and Proliferation under Hypoxia through Regulation of miR‑34a‑5p/KLF4 in Vitro. Molecular Medicine Reports, 24, Article No. 749. https://doi.org/10.3892/mmr.2021.12389
|
[193]
|
Wu, Z.H., Zhou, J., Hu, G.H., et al. (2021) LncRNA CASC2 Inhibits Lung Adenocarcinoma Progression through Forming Feedback Loop with miR-21/p53 Axis. The Kaohsiung Journal of Medical Sciences, 37, 675-685.
https://doi.org/10.1002/kjm2.12386
|
[194]
|
Gong, J., Chen, Z., Chen, Y., et al. (2019) Long Non-Coding RNA CASC2 Suppresses Pulmonary Artery Smooth Muscle Cell Proliferation and Phenotypic Switch in Hypoxia-Induced Pulmonary Hypertension. Respiratory Research, 20, Article No. 53. https://doi.org/10.1186/s12931-019-1018-x
|
[195]
|
Han, Y., Liu, Y., Yang, C., et al. (2020) LncRNA CASC2 Inhibits Hypoxia-Induced Pulmonary Artery Smooth Muscle Cell Proliferation and Migration by Regulating the miR-222/ING5 Axis. Cell & Molecular Bio Letters, 25, Article No. 21. https://doi.org/10.1186/s11658-020-00215-y
|
[196]
|
Liu, Y., Hu, R., Zhu, J., et al. (2021) The lncRNA PAHRF Functions as a Competing Endogenous RNA to Regulate MST1 Expression by Sponging miR-23a-3p in Pulmonary Arterial Hypertension. Vascular Pharmacology, 139, Article ID: 106886. https://doi.org/10.1016/j.vph.2021.106886
|
[197]
|
Kino, T., Hurt, D.E., Ichijo, T., Nader, N. and Chrousos, G.P. (2010) Noncoding RNA gas5 Is a Growth Arrest and Starvation-Associated Repressor of the Glucocorticoid Receptor. Science Signaling, 3, ra8.
https://doi.org/10.1126/scisignal.2000568
|
[198]
|
Gao, Z.Q., Wang, J.F., Chen, D.H., et al. (2017) Long Non-Coding RNA GAS5 Suppresses Pancreatic Cancer Metastasis through Modulating miR-32-5p/PTEN Axis. Cell & Bioscience, 7, Article No. 66.
https://doi.org/10.1186/s13578-017-0192-0
|
[199]
|
Li, Y., Gu, J. and Lu, H. (2017) The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells through the PTEN/Akt/mTOR Pathway. Digestive Diseases and Sciences, 62, 3426-3437.
https://doi.org/10.1007/s10620-017-4831-4
|
[200]
|
Tang, R., Zhang, G., Wang, Y.C., et al. (2017) The Long Non-Coding RNA GAS5 Regulates Transforming Growth Factor β (TGF-β)-Induced Smooth Muscle Cell Differentiation via RNA Smad-Binding Elements. Journal of Biological Chemistry, 292, 14270-14278. https://doi.org/10.1074/jbc.M117.790030
|
[201]
|
Hao, X., Li, H., Zhang, P., et al. (2020) Down-Regulation of lncRNA Gas5 Promotes Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation by Regulating KCNK3 Expression. European Journal of Pharmacology, 889, Article ID: 173618. https://doi.org/10.1016/j.ejphar.2020.173618
|
[202]
|
Feng, X., Wang, K., Yang, T., et al. (2022) LncRNA-GAS5/miR-382-3p Axis Inhibits Pulmonary Artery Remodeling and Promotes Autophagy in Chronic Thromboembolic Pulmonary Hypertension. Genes Genomics, 44, 395-404.
https://doi.org/10.1007/s13258-021-01202-z
|
[203]
|
Liu, Y., Zhang, H., Li, Y., et al. (2020) Long Noncoding RNA Rps4l Mediates the Proliferation of Hypoxic Pulmonary Artery Smooth Muscle Cells. Hypertension, 76, 1124-1133. https://doi.org/10.1161/HYPERTENSIONAHA.120.14644
|
[204]
|
Li, Y., Zhang, J., Sun, H., et al. (2021) lnc-Rps4l-Encoded Peptide RPS4XL Regulates RPS6 Phosphorylation and Inhibits the Proliferation of PASMCs Caused by Hypoxia. Molecular Therapy, 29, 1411-1424.
https://doi.org/10.1016/j.ymthe.2021.01.005
|
[205]
|
Li, Y., Zhang, J., Sun, H., et al. (2022) RPS4XL Encoded by lnc-Rps4l Inhibits Hypoxia-Induced Pyroptosis by Binding HSC70 Glycosylation Site. Molecular Therapy Nucleic Acids, 28, 920-934.
https://doi.org/10.1016/j.omtn.2022.05.033
|
[206]
|
Liu, Y., Sun, Z., Zhu, J., et al. (2018) LncRNA-TCONS_00034812 in Cell Proliferation and Apoptosis of Pulmonary Artery Smooth Muscle Cells and Its Mechanism. Journal of Cellular Physiology, 233, 4801-4814.
https://doi.org/10.1002/jcp.26279
|
[207]
|
Lin, D., Zhang, X., Zhang, C., et al. (2021) LncRNA-TCONS_00034812 Is Upregulated in Atherosclerosis and Upregulates miR-21 through Methylation in Vascular Smooth Muscle Cells. Annals of Translational Medicine, 9, 1005.
https://doi.org/10.21037/atm-21-2632
|
[208]
|
Pasmant, E., Laurendeau, I., Héron, D., et al. (2007) Characterization of a Germ-Line Deletion, Including the Entire INK4/ARF Locus, in a Melanoma-Neural System Tumor Family: Identification of ANRIL, an Antisense Noncoding RNA Whose Expression Coclusters with ARF. Cancer Research, 67, 3963-3969.
https://doi.org/10.1158/0008-5472.CAN-06-2004
|
[209]
|
Chen, L., Qu, H., Guo, M., et al. (2020) ANRIL and Atherosclerosis. Journal of Clinical Pharmacy and Therapeutics, 45, 240-248. https://doi.org/10.1111/jcpt.13060
|
[210]
|
Wang, S., Zhang, C. and Zhang, X. (2020) Downregulation of Long Non‑Coding RNA ANRIL Promotes Proliferation and Migration in Hypoxic Human Pulmonary Artery Smooth Muscle Cells. Molecular Medicine Reports, 21, 589-596.
https://doi.org/10.3892/mmr.2019.10887
|
[211]
|
Deng, L., Chen, J., Chen, B., et al. (2022) LncPTSR Triggers Vascular Remodeling in Pulmonary Hypertension by Regulating [Ca2+]i in Pulmonary Arterial Smooth Muscle Cells. American Journal of Respiratory Cell and Molecular Biology, 66, 524-538. https://doi.org/10.1165/rcmb.2020-0480OC
|
[212]
|
Wu, G., Cai, J., Han, Y., et al. (2014) LincRNA-p21 Regulates Neointima Formation, Vascular Smooth Muscle Cell Proliferation, Apoptosis, and Atherosclerosis by Enhancing p53 Activity. Circulation, 130, 1452-1465.
https://doi.org/10.1161/CIRCULATIONAHA.114.011675
|
[213]
|
Wang, H., He, F., Liang, B., et al. (2021) p53-Dependent LincRNA-p21 Protects against Proliferation and Anti-Apoptosis of Vascular Smooth Muscle Cells in Atherosclerosis by Upregulating SIRT7 via MicroRNA-17-5p. Journal of Cardiovascular Translational Research, 14, 426-440. https://doi.org/10.1007/s12265-020-10074-9
|
[214]
|
Leisegang, M.S., Fork, C., Josipovic, I., et al. (2017) Long Noncoding RNA MANTIS Facilitates Endothelial Angiogenic Function. Circulation, 136, 65-79. https://doi.org/10.1161/CIRCULATIONAHA.116.026991
|
[215]
|
Wu, Q., Zhou, X., Wang, Y., et al. (2022) LncRNA GAS5 Promotes Spermidine-Induced Autophagy through the miRNA-31-5p/NAT8L Axis in Pulmonary Artery Endothelial Cells of Patients with CTEPH. Molecular Medicine Reports, 26, Article No. 297. https://doi.org/10.3892/mmr.2022.12813
|
[216]
|
Gofrit, O.N., Benjamin, S., Halachmi, S., et al. (2014) DNA Based Therapy with Diphtheria Toxin-A BC-819: A Phase 2b Marker Lesion Trial in Patients with Intermediate Risk Nonmuscle Invasive Bladder Cancer. Journal of Urology, 191, 1697-1702. https://doi.org/10.1016/j.juro.2013.12.011
|
[217]
|
Smaldone, M.C. and Davies, B.J. (2010) BC-819, a Plasmid Comprising the H19 Gene Regulatory Sequences and Diphtheria Toxin A, for the Potential Targeted Therapy of Cancers. Current Opinion in Molecular Therapeutics, 12, 607-616.
|
[218]
|
Gomes, C.P.C., Spencer, H., Ford, K.L., et al. (2017) The Function and Therapeutic Potential of Long Non-Coding RNAs in Cardiovascular Development and Disease. Molecular Therapy Nucleic Acids, 8, 494-507.
https://doi.org/10.1016/j.omtn.2017.07.014
|